Investigational Drug Details
| Drug ID: | D530 |
| Drug Name: | GDD3898 |
| Synonyms: | GDD-3898 |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | Hepatoprotectants; Obesity therapies |
| Clinical Trial Progress: | Phase 1 on-going (ACTRN12622000171718) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0369 | ACTRN12622000171718 | Phase 1 | Not Recruiting | No Results Available | 02/02/2022 | 7 February 2022 | Details |
| L0392 | ACTRN12621000255886 | Phase 1 | Not Recruiting | No Results Available | 10/03/2021 | 18 October 2021 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|